Multiple Myeloma Drugs Market is Expected to Reach CAGR of 9.19% Multiple Myeloma Drugs Market 2017-2021 | Página 2

The report covers the present scenario and the growth prospects of the global multiple myeloma
drugs market for 2017-2021. To calculate the market size, the report considers the revenue
generated from the sales of branded and generic drugs used to treat and prevent multiple
myeloma.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Global Multiple Myeloma Drugs Market 2017-2021, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a discussion of the key vendors
?operating in this market.
Related reports by Radiant Insights:
http://www.radiantinsights.com/catalog/healthcare
Key vendors
• Amgen
• Celgene
• Johnson & Johnson
• Novartis
• Takeda Pharmaceuticals
Other prominent vendors
• AB Science
• AbbVie
• Acceleron Pharma
• Acetylon Pharmaceuticals
• Adaptimmune Therapeutics
Follow Us: